Chugai Pharmaceutical Co., Ltd. (CHGCY)
Develops cancer drugs and biologics for patients worldwide.
$21.41+0.02%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-12.8%
The outlook
CHGCY is trading well below its 50- and 200-day moving averages, sitting near the lower end of its 52-week range. The stock carries a trailing P/E of 24.3, and analyst sentiment leans bearish with minimal recent momentum.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range12% of the way from its 52-week low to high
Market cap
$70.47B
52-wk high
$34.84
52-wk low
$19.50
50-day avg
$23.38
200-day avg
$26.01
Trailing P/E
24.3